Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.

Trial Details

NCT ID
NCT06446661
Phase
NA
Sponsor
University of Chicago
Status
RECRUITING
Cancer Type
Lymphoma
Interventions
  • High Intensity
  • No Text Messagings
  • Low Intensity Text Messaging
Locations (sample)
  • Chicago, Illinois, United States|41.85003,-87.65005

Key Eligibility Criteria

  • Age of 15 years or older at time of enrollment
  • Diagnosed with ALL or T-cell lymphoblastic lymphoma
  • Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Stud…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lymphoma Trials on Trialify →